Hidoc Dr | Medical Learning App for Doctors

Today's Updates

Pair Echo With Right Heart Catheterization in PH: Anjali Vaidya, MD Anjali Vaidya, MD, FACC, FASE, FACP

Published Date: 27 Oct 2026

Anjali Vaidya, MD, explains why echocardiography should inform right heart catheterization interpretation in pulmonary hypertension at CHEST 2026.

New Trials Favor PE Intervention in Sicker Intermediate-Risk Patients Samantha Pettigrew, MD

Published Date: 27 Oct 2026

Samantha Pettigrew, MD, reviews HI-PEITHO, PRAGUE-26, and PEERLESS and how they shape intervention choices in intermediate-risk PE at CHEST 2026.

CAR-T Agent Zola-cel Shows No New Multiple Sclerosis Disease Activity in Phase 1 Study Louie Pasculli

Published Date: 27 Oct 2026

Updated data from Breakfree-2 study showed that treatment with a single zola-cel infusion achieved NEDA-3 in highly active relapsing multiple sclerosis and led to mostly stable disability in progressive multiple sclerosis.

Remibrutinib Lowers Relapse Rate vs Teriflunomide in Relapsing MS Matt Hoffman, Louie Pasculli

Published Date: 27 Oct 2026

Phase 3 data show the oral BTK inhibitor reduced annualized relapse rate by 35.2% and 31.2% vs teriflunomide, with no liver safety signal or Hy's Law cases.

Houston Forum Highlights Awareness Gaps in NF1 Plexiform Neurofibroma Care Marco Meglio

Published Date: 27 Oct 2026

At a NeurologyLive and Targeted Oncology Clinical Forum in Houston, Kevin J. Bielamowicz, MD, of Arkansas Children’s Hospital, discussed how incidental diagnosis and limited awareness of systemic therapy continue to delay care for patients with NF1-associated plexiform neurofibromas.

Tenecteplase Benefit Before Thrombectomy Varies by Stroke Cause, Study Shows Marco Meglio

Published Date: 27 Oct 2026

A secondary analysis of the BRIDGE-TNK trial found tenecteplase before thrombectomy improved functional outcomes in cardioembolic but not atherosclerotic stroke.

NeurologyLive® Brain Games: October 25, 2026 Louie Pasculli, Marco Meglio

Published Date: 27 Oct 2026

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is recent advances in gene therapies.

Interpreting Kidney Donor Pregnancy Signals, With Amit Garg, MD, PhD Amit X. Garg, MD, PhD

Published Date: 27 Oct 2026

Chance, biology, and shared genetics may explain more small for gestational age births after living kidney donation.

Pentoxifylline in Diabetic Kidney Disease: What the Evidence Shows Rajiv Agarwal, MD, MS

Published Date: 27 Oct 2026

Rajiv Agarwal, MD, MS, explains why decades of pentoxifylline data in DKD remain inconclusive and how the VA PTXRx trial aims to settle the question.

Does CKD Require Restricting Potassium-Rich Foods? With Navdeep Tangri, MD Navdeep Tangri, MD

Published Date: 27 Oct 2026

In a randomized crossover trial, a liberalized produce diet raised urinary potassium excretion without changing serum potassium.

Knowledge Hub

Oncology

Resistance Exercise During Cancer Rehabilitation

A clinical review of resistance exercise in cancer rehabilitation, including mechanisms, safety screening, assessment, treatment principles, emerging evidence, and guideline-based practice.

Oncology

Tumor Cell Dormancy Sustained by Extracellular Matrix Mechanical Signaling

A medical review of how extracellular matrix mechanics regulate tumor cell dormancy, metastatic relapse, diagnosis, treatment, and emerging mechanotransduction therapies.

Oncology

Tumor-Associated Glycoprotein Signatures During Cancer Evolution

A scientific review of how tumor-associated glycoprotein signatures evolve during cancer progression and their potential roles in diagnosis, prognosis, treatment, and precision oncology.

Oncology

Digital Oral Oncology Care Pathways

A clinical review of digital oral oncology pathways, covering early detection, diagnosis, treatment coordination, remote monitoring, emerging technologies, and guideline-based implementation.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Pair Echo With Right Heart Catheterization in PH: Anjali Vaidya, MD Anjali Vaidya, MD, FACC, FASE, FACP

New Trials Favor PE Intervention in Sicker Intermediate-Risk Patients Samantha Pettigrew, MD

CAR-T Agent Zola-cel Shows No New Multiple Sclerosis Disease Activity in Phase 1 Study Louie Pasculli

Remibrutinib Lowers Relapse Rate vs Teriflunomide in Relapsing MS Matt Hoffman, Louie Pasculli

Houston Forum Highlights Awareness Gaps in NF1 Plexiform Neurofibroma Care Marco Meglio

Tenecteplase Benefit Before Thrombectomy Varies by Stroke Cause, Study Shows Marco Meglio

NeurologyLive® Brain Games: October 25, 2026 Louie Pasculli, Marco Meglio

Interpreting Kidney Donor Pregnancy Signals, With Amit Garg, MD, PhD Amit X. Garg, MD, PhD

Pentoxifylline in Diabetic Kidney Disease: What the Evidence Shows Rajiv Agarwal, MD, MS

Does CKD Require Restricting Potassium-Rich Foods? With Navdeep Tangri, MD Navdeep Tangri, MD

Knowledge Hub

Resistance Exercise During Cancer Rehabilitation

Tumor Cell Dormancy Sustained by Extracellular Matrix Mechanical Signaling

Tumor-Associated Glycoprotein Signatures During Cancer Evolution

Digital Oral Oncology Care Pathways

Reducing Childhood Cancer Risk From Environmental Exposures

Molecular Subtyping for Individualized Cancer Care

Community-Based Cancer Prevention Through Environmental Risk Mapping

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Pair Echo With Right Heart Catheterization in PH: Anjali Vaidya, MD Anjali Vaidya, MD, FACC, FASE, FACP

New Trials Favor PE Intervention in Sicker Intermediate-Risk Patients Samantha Pettigrew, MD

CAR-T Agent Zola-cel Shows No New Multiple Sclerosis Disease Activity in Phase 1 Study Louie Pasculli

Remibrutinib Lowers Relapse Rate vs Teriflunomide in Relapsing MS Matt Hoffman, Louie Pasculli

Houston Forum Highlights Awareness Gaps in NF1 Plexiform Neurofibroma Care Marco Meglio

Tenecteplase Benefit Before Thrombectomy Varies by Stroke Cause, Study Shows Marco Meglio

NeurologyLive® Brain Games: October 25, 2026 Louie Pasculli, Marco Meglio

Interpreting Kidney Donor Pregnancy Signals, With Amit Garg, MD, PhD Amit X. Garg, MD, PhD

Pentoxifylline in Diabetic Kidney Disease: What the Evidence Shows Rajiv Agarwal, MD, MS

Does CKD Require Restricting Potassium-Rich Foods? With Navdeep Tangri, MD Navdeep Tangri, MD

Knowledge Hub

Resistance Exercise During Cancer Rehabilitation

Tumor Cell Dormancy Sustained by Extracellular Matrix Mechanical Signaling

Tumor-Associated Glycoprotein Signatures During Cancer Evolution

Digital Oral Oncology Care Pathways

Reducing Childhood Cancer Risk From Environmental Exposures

Molecular Subtyping for Individualized Cancer Care

Community-Based Cancer Prevention Through Environmental Risk Mapping

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views